Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial (Q37381097)
Jump to navigation
Jump to search
scientific article published on December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial |
scientific article published on December 2013 |
Statements
1 reference
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial (English)
1 reference
Julianna Lisziewicz
1 reference
Benigno Rodriguez
1 reference
David M Asmuth
1 reference
Roy M Matining
1 reference
John Spritzler
1 reference
Jeffrey M Jacobson
1 reference
Xiao-Dong Li
1 reference
Ana I Martinez
1 reference
Allan R Tenorio
1 reference
Franco Lori
1 reference
Suria Yesmin
1 reference
Charles R Rinaldo
1 reference
Richard B Pollard
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference